Septerna (SEPN) Cash from Operations (2023 - 2026)
Septerna's quarterly Cash from Operations came in at 25633000.0 in Q1 2026, down 9.81% year-on-year from 28421180.78 in Q1 2025, and down 71.02% quarter-over-quarter from 14988000.0 in Q4 2025.
Septerna has reported Cash from Operations for 4 years, with the latest figure at 25633000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations fell 9.81% year-over-year to 25633000.0; the trailing twelve-month figure through Mar 2026 stood at 107899000.0 (up 245.61% YoY), and the FY2025 full-year result was 110189000.0, up 263.32% from the prior year.
- Cash from Operations for Q1 2026 stood at 25633000.0, down from 14988000.0 in the prior quarter.
- The five-year high for Cash from Operations was 168807000.0 in Q3 2025, with the low at 25633000.0 in Q1 2026.
- Average Cash from Operations over 4 years is 828900.0, with a median of 16762500.0 recorded in 2024.
- Year-over-year, Cash from Operations sank 138.24% in 2024 and surged 1103.97% in 2025.
- Tracing SEPN's Cash from Operations over 4 years: stood at 8797000.0 in 2023, then plunged by 138.24% to 20958000.0 in 2024, then rose by 28.49% to 14988000.0 in 2025, then slumped by 71.02% to 25633000.0 in 2026.
- The last three Cash from Operations figures came in at 25633000.0 (Q1 2026), 14988000.0 (Q4 2025), and 168807000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Septerna | 1.34 Bn | 1.34 Bn | - | -25.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.63 Mn |
| Mar 31, 2026 | -25.63 Mn |
| Dec 31, 2025 | -14.99 Mn |
| Dec 31, 2025 | -14.99 Mn |
| Sep 30, 2025 | 168.81 Mn |
| Sep 30, 2025 | 168.81 Mn |
| Jun 30, 2025 | -20.29 Mn |
| Jun 30, 2025 | -20.29 Mn |
| Mar 31, 2025 | -23.34 Mn |
| Mar 31, 2025 | -23.34 Mn |
| Dec 31, 2024 | -20.96 Mn |
| Dec 31, 2024 | -20.96 Mn |
| Sep 30, 2024 | -16.81 Mn |
| Sep 30, 2024 | -16.81 Mn |
| Jun 30, 2024 | -12.99 Mn |
| Jun 30, 2024 | -12.99 Mn |
| Mar 31, 2024 | -16.71 Mn |
| Mar 31, 2024 | -16.71 Mn |
| Dec 31, 2023 | -8.80 Mn |
| Dec 31, 2023 | -8.80 Mn |